SALIVARY ELIMINATION OF PYRIMETHAMINE

[1] PHARMACOKINETICS AND PROTEIN-BINDING INTERACTIONS OF DAPSONE AND PYRIMETHAMINE [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (05) : 519 - 524

[2] CAVALLITO JC, 1978, DRUG METAB DISPOS, V6, P329

[3] COHN VH, 1971, FUNDAMENTALS DRUG ME, P18

[4] THERAPEUTIC DRUG MONITORING IN SALIVA [J]. CLINICAL PHARMACOKINETICS, 1978, 3 (01) : 39 - 57

[5] GALEAZZI RL, 1976, CLIN PHARMACOL THER, V20, P278

[6] TREATMENT OF MENINGEAL LEUKEMIA WITH PYRIMETHAMINE [J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1971, 38 (02): : 131 - +

[7] DETERMINATION OF PLASMA-CONCENTRATIONS OF DAPSONE, MONOACETYL DAPSONE AND PYRIMETHAMINE IN HUMAN-SUBJECTS DOSED WITH MALOPRIM [J]. JOURNAL OF CHROMATOGRAPHY, 1979, 163 (02): : 179 - 185

[8] MATIN SB, 1974, CLIN PHARMACOL THER, V16, P1052

[9] PERSISTENT EXCRETION OF PYRIMETHAMINE FOLLOWING ORAL ADMINISTRATION [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1959, 8 (01) : 60 - 62

[1] PHARMACOKINETICS AND PROTEIN-BINDING INTERACTIONS OF DAPSONE AND PYRIMETHAMINE [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (05) : 519 - 524

[2] CAVALLITO JC, 1978, DRUG METAB DISPOS, V6, P329

[3] COHN VH, 1971, FUNDAMENTALS DRUG ME, P18

[4] THERAPEUTIC DRUG MONITORING IN SALIVA [J]. CLINICAL PHARMACOKINETICS, 1978, 3 (01) : 39 - 57

[5] GALEAZZI RL, 1976, CLIN PHARMACOL THER, V20, P278

[6] TREATMENT OF MENINGEAL LEUKEMIA WITH PYRIMETHAMINE [J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1971, 38 (02): : 131 - +

[7] DETERMINATION OF PLASMA-CONCENTRATIONS OF DAPSONE, MONOACETYL DAPSONE AND PYRIMETHAMINE IN HUMAN-SUBJECTS DOSED WITH MALOPRIM [J]. JOURNAL OF CHROMATOGRAPHY, 1979, 163 (02): : 179 - 185

[8] MATIN SB, 1974, CLIN PHARMACOL THER, V16, P1052

[9] PERSISTENT EXCRETION OF PYRIMETHAMINE FOLLOWING ORAL ADMINISTRATION [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1959, 8 (01) : 60 - 62